Clinical trial
Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
NCT00003686 · NCIC Clinical Trials Group, Other · Terminated
Key facts
| NCT number | NCT00003686 |
|---|---|
| Title | Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids |
| Official title | A Double Blind Phase III Study of Oral Pilocarpine for Opioid-Induced Dry Mouth |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Oral Complications, Quality of Life |
| Intervention type | Drug |
| Interventions | pilocarpine hydrochloride, Placebo |
| Enrollment | 4 |
| Start date | May 22, 1998 |
| Primary completion | Nov 1, 2007 |
| Completion | Dec 15, 2008 |
| First posted | Aug 17, 2004 |
| Last update posted | Apr 3, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: